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Selective mutism (SM) is a diagnosis marked by withdrawal of speech in certain social 
situations. The treatment of SM is often a difficult and lengthy process and there are many 
barriers to successful intervention. Behavioral therapy is most effective in the treatment of SM 
and the addition of therapeutic activities such as games and mobile devices may provide distinct 
advantages to this treatment (i.e., decreased patient anxiety levels and more active engagement). 
The current investigation examined the utility of mobile applications during the behavioral 
treatment of SM as well as the effect of using mobile applications on child-reported and 
physiological indicators of anxious responding. Results indicated that children made remarkable 
treatment gains in just two treatment sessions (i.e., spoke to the clinician within 22 minutes of 
treatment and held five, five-minute conversations with additional adults during a second 
session) regardless of modality of delivery (using mobile applications, other activities, or 
reinforcement alone). Children shaped to speak with the inclusion of mobile applications 
reported less anxiety and exhibited decreased physiological anxious distress during treatment. 
The utility of mobile applications during the treatment of SM is discussed in addition to areas for 










The author wishes to acknowledge his mentor, Dr. Deborah Beidel, for her unconditional 
compassion, understanding, and patience throughout the past 5 years. She is an exemplary model 
of a true scientist practitioner. She is caring and nurturing, and exudes passion for teaching and 
mentorship. Her teachings will live on through generations of future scientists, all of whom are 
better for having learned under her tutelage. She is not only a mentor, but a friend who is always 
there for those in need. 
The author also wishes to express his gratitude to his dissertation committee as well as 
the researchers at the University of Central Florida for their help and support throughout the 
course of this study, particularly Franklin Mesa, who is a true friend and was integral in the 
completion of this work. 
The author also would like to thank and acknowledge his wife, Dr. Avianne Bunnell, who 
has made all of this possible. Her encouragement during the hardest of times made even the most 
difficult barriers passable. Her love and strength bolsters those around her, and her enduring 






TABLE OF CONTENTS 
LIST OF FIGURES ..................................................................................................................... viii 
LIST OF TABLES ......................................................................................................................... ix 
LIST OF ACRONYMS .................................................................................................................. x 
INTRODUCTION .......................................................................................................................... 1 
Selective Mutism ........................................................................................................................ 1 
Treatment of Selective Mutism ................................................................................................... 2 
Comprehensive Intervention for SM and the Use of Activities in Treatment ............................ 4 
Using Mobile Applications to Treat Selective Mutism .............................................................. 5 
STUDY 1: REPLICATION AND EXTENSION ........................................................................... 7 
METHOD ....................................................................................................................................... 8 
Procedure .................................................................................................................................... 8 
Design ......................................................................................................................................... 8 
Participants .................................................................................................................................. 8 
Assessment .................................................................................................................................. 9 
Diagnostic interview. ............................................................................................................... 9 
Child social anxiety ............................................................................................................... 10 
Behavioral Assessment .......................................................................................................... 10 
Treatment .................................................................................................................................. 10 
vi 
 
RESULTS ..................................................................................................................................... 13 
Behavioral Assessment ............................................................................................................. 13 
Within-session speaking ........................................................................................................ 13 
Within-session latency to speak ............................................................................................ 13 
Within-session anxiety .......................................................................................................... 14 
DISCUSSION ............................................................................................................................... 15 
STUDY 2: MECHANISMS OF CHANGE DURING TREATMENT: INTRODUCTION........ 17 
Systematic Desensitization ....................................................................................................... 17 
METHOD ..................................................................................................................................... 20 
Procedure .................................................................................................................................. 20 
Design ....................................................................................................................................... 20 
Participants ................................................................................................................................ 21 
Assessment ................................................................................................................................ 22 
Diagnostic interview. ............................................................................................................. 22 
Child and parent report of social anxiety. .............................................................................. 23 
Behavioral assessment ........................................................................................................... 23 
Physiological assessment of anxious arousal ........................................................................ 23 
Treatment .................................................................................................................................. 23 
RESULTS ..................................................................................................................................... 26 
vii 
 
Data Analysis ............................................................................................................................ 26 
Behavioral Assessment ............................................................................................................. 27 
Hierarchy completion and speaking behavior. ...................................................................... 27 
Note. M = Mean; SD = Standard Deviation. ......................................................................... 28 
Child-reported anxiety. .......................................................................................................... 28 
Physiological assessment of anxious arousal ............................................................................ 32 
DISCUSSION ............................................................................................................................... 37 
APPENDIX A: IRB APPROVAL LETTER ................................................................................ 45 
APPENDIX B: HEART RATE DATA ........................................................................................ 48 





LIST OF FIGURES 
Figure 1 Number of Adults Spoken to During Each Session ....................................................... 13 
 Figure 2 Within-Session Anxiety Ratings ................................................................................... 14 
Figure 3 Average Self-Reported Anxiety Ratings in Relation to Baseline Ratings for Session 1 30 
Figure 4 Average Self-Reported Anxiety Ratings in Relation to Baseline Ratings for Session 2 31 




LIST OF TABLES 
Table 1 Participant Demographic and Assessment Data ................................................................ 9 
Table 2 Mobile Applications Used During Each Session ............................................................. 12 
Table 3 Within-Session Latency to Speak .................................................................................... 14 
Table 4 Participant Demographic, Diagnostic, and Social Anxiety Severity Data ...................... 22 
Table 5 Mobile Applications Used During Each Session ............................................................. 25 
Table 6 Behavioral Assessment of Hierarchy Completion and Speaking Behavior .................... 28 
Table 7 Comparisons in HRV among Participants for Session 1 ................................................. 33 
Table 8 Comparisons in HRV among Participants for Session 2 ................................................. 34 
Table 9 Comparisons in EDA among Participants for Session 1 ................................................. 35 
Table 10 Comparisons in EDA among Participants for Session 2 ............................................... 36 
Table 11 Comparisons in HR among Participants for Session 1 .................................................. 49 





LIST OF ACRONYMS 
aBT  Behavior Therapy + Other Activities 
ADIS-C/P  Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions 
APA   American Psychiatric Association 
BT  Behavior Therapy Alone Group 
DSM-5  Diagnostic and Statistical Manual for Mental Disorders - Fifth Edition 
EDA   Electrodermal Activity 
GAD  Generalized Anxiety Disorder  
HRV  Heart Rate Variability 
iBT   Behavior Therapy + Mobile Application Group 
PAND  Percentage of All Non-Overlapping Data 
PC  Personal Computer 
SAD   Social Anxiety Disorder 
SepAnx  Separation Anxiety Disorder  
SM   Selective Mutism 
SPAI-C  Social Phobia and Anxiety Inventory for Children 






Selective Mutism (SM) is a disorder marked by a consistent failure to speak in particular 
social situations during which speech is expected (e.g., at school), despite speaking in other 
situations (e.g., in the home). Functional impairment in academic or social achievement often 
occurs, and is required for the diagnosis according to the Diagnostic and Statistical Manual for 
Mental Disorders - Fifth Edition (DSM-5; American Psychiatric Association [APA], 2013). SM 
is a rare disorder with a prevalence of less than 1% of the general population (Bergman, 
Piacentini, & McCracken, 2002; Chavira, Stein, Bailey, & Stein, 2004; Elizur & Perednik, 2003; 
Steinhausen & Juzi, 1996; Viana, Beidel, & Rabian, 2009). SM is diagnosed typically in 
childhood and has an average age of onset ranging from 2.7 to 4.1 years (Cunningham, McHolm, 
Boyle, & Patel, 2004; Garcia, Freeman, Francis, Miller, & Leonard, 2004). 
 In the DSM-5, SM was moved from its original placement in the Other Disorders of 
Childhood and Adolescence diagnostic category to the Anxiety Disorders category. The rationale 
for placement in this category included the many empirical findings that, more often than not, 
SM co-occurs with other anxiety disorders (APA, 2013). Of particular interest to researchers has 
been the relationship between SM and social anxiety (see Viana et al. 2009, for a review). Due to 
the similar clinical presentations of SM and social anxiety disorder (SAD; a disorder 
characterized by intense fear and avoidance of social interactions; APA, 2013) it has been 
postulated that SM may represent a developmental variant of SAD (Anstendig, 1999; Bergman et 
al., 2002; Black & Uhde, 1992; Silveira, Jainer, & Bates, 2004). Some findings suggest that 
children with SM report being too afraid to speak in social situations and the lack of speech 
represents a behavioral avoidance mechanism (Black & Uhde, 1995; Dummit, Klein, Tancer, & 
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Asche, 1997; Sharp, Sherman, & Gross, 2007; Vecchio & Kearney 2005; Young, Bunnell, & 
Beidel, 2012). Further studies supporting the diagnostic overlap include data that approximately 
80 to 97% of children with SM also meet diagnostic criteria for SAD (Black & Uhde, 1995; 
Young et al., 2012), and relatedly, children with SM report elevated levels of social anxiety and 
shyness (Carbone et al., 2010; Cunningham et al., 2004; Dummitt et al., 1997; Steinhausen & 
Juzi, 1996). Additional research indicates high familial loadings for anxiety disorders, 
particularly social anxiety disorder (Black & Uhde, 1995; Chavira, Shipon-Blum, & Stein, 2005; 
Kolvin & Fundudis, 1981; Kristensen & Torgersen, 2001). From an experimental/behavioral 
perspective, children with SM often benefit from treatments that reduce social anxiety, both 
pharmacological (Black & Uhde, 1994; Harvey & Milne, 1998; Lafferty & Constantino, 1998; 
Lehman, 2002; Maskey, 2001; Thomsen, Rasmussen, & Anderson, 1999) and 
cognitive/behavioral (see Anstendig, 1998; Cohan, Chavira, & Stein, 2006; Pionek Stone, 
Kratochwill, Sladezcek, & Serlin, 2002; Viana et al., 2009 for reviews). 
Treatment of Selective Mutism 
Treating SM is a difficult and often lengthy process, with some studies reporting 
intervention lengths up to six to eight months (e.g., Bergman, Gonzalez, Piacentini, & Keller, 
2013; Nolan & Pence, 1970). Treatment barriers include positive and negative reinforcement for 
not speaking in certain environments (e.g., Mowrer’s two factor theory; Mowrer, 1947), the 
child’s resistance to treatment (Krysanski, 2003), and potentially the child’s reputation or 
identity as “the kid who does not talk” (Bunnell & Beidel, 2013). Further, as proposed by 
Bunnell and Beidel (2013) “adult attention/pleas to speak often develop a paradoxical behavioral 
response from the child (i.e., as the adults plead with the child to speak, that attention may 
reinforce lack of speech)” (pp. 292). Difficulty with treatment also may be related to the sparse 
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literature examining the efficacy of treatments for the disorder. The overwhelming majority of 
the extant treatment literature in this population consists of case studies and single case designs 
whereas there have been only four studies providing group comparisons following treatment 
(i.e., Bergman, Gonzalez, Piacentini, & Keller, 2013; Manassis & Tannock, 2008; Oerbeck, 
Stein, Wentzel-Larsen, Langsrud, & Kristensen, 2014; Sluckin, Foreman, & Herbert, 1991), and 
only two of these investigations included a prospective, randomized control design (i.e., 
Bergman et al., 2013 and Oerbeck et al., 2014). The most recent meta-analysis examining 
treatment for SM was published over a decade ago, and supported the use of behavior therapy in 
the treatment of SM (Pionek Stone, Kratochwill, Sladezcek, & Serlin, 2002).  
The most commonly used interventions for SM include contingency management and 
shaping (Amari, Keith, Arlene, Schenick, & Kane, 1999; Bunnell & Beidel, 2013; Facon, Sahiri, 
& Riviere, 2008; Marino Fernandez, 1986; Guna-Dumitrescu & Pelletier, 1996; Masten, Stacks, 
Caldwell-Colbert, & Jackson, 1996; Nolan & Pence, 1970; Oerbeck, Johansen, Lundahl, & 
Kristensen, 2011; Porjes, 1992), stimulus fading (Beare, Torgerson, & Creviston, 2008; Kehle, 
Madaus, Baratta, & Bray 1998; Masten, Stacks, Caldwell-Colbert, & Jackson, 1996; Nolan & 
Pence, 1970; Oerbeck et al., 2011; Watson & Kramer, 1992), systematic 
desensitization/exposure (Bunnell & Beidel, 2013; Kee, Fung, & Ang, 2001; Rasbury, 1974; Rye 
& Ullman, 1999; Vecchio & Kearney, 2007; Vecchio & Kearney, 2009), self-modeling (Kehle et 
al., 1998), and social skills training (Bunnell & Beidel, 2013; Fisak, Oliveros, & Ehrenreich, 
2006; Reuther, Davis, Moree, & Matson, 2011). Contingency management is often the first step 
in the treatment process. Rewards are contingent on compliance with directions from the 
therapist and parents, such as to produce verbalizations. Over time, rewards become contingent 
upon reaching treatment goals of increased difficulty (e.g., speaking at louder volumes or 
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verbalizing words rather than sounds), which may be likened to the rewarding of successive 
approximations of speech (i.e., shaping, although in this case “speaking to unfamiliar people” is 
the new behavior being learned). Stimulus fading involves the progressive introduction of 
additional stimuli (e.g., persons or settings) as the child speaks to someone with whom he or she 
is comfortable speaking. Systematic desensitization/exposure therapy is useful particularly when 
SM co-occurs with social anxiety. Systematic desensitization involves the presentation of a 
mood state (relaxation/enjoyment) incompatible with anxiety when the individual is in the 
presence of the anxiety-producing event or situation. Although some efficacy has been 
demonstrated when using these interventions separately, increased clinical efficacy may result 
when shaping, stimulus fading and exposure are combined. 
Comprehensive Intervention for SM and the Use of Activities in Treatment 
Many investigations have used a combination of behavioral methods in treating SM. 
Often referred to as “modular cognitive-behavioral treatments” or “multidisciplinary 
interventions” (e.g., Christon et al., 2012; Giddan, Ross, Sechler, & Becker, 1997), these 
interventions have resulted in decreased social anxiety and decreased functional impairment 
associated with SM, as well as increased speech production across settings. These 
multidisciplinary interventions have varied in delivery, but appear to include common behavioral 
methods. Specifically, some success has been noted when using behavioral methods such as 
psychoeducation, contingency management, shaping, self-modeling, cognitive restructuring, 
relaxation, exposure, systematic desensitization, stimulus generalization/fading, social skills, and 
parent training (Bergman et al., 2013; Bunnell & Beidel, 2013; Christon et al., 2012; Giddan et 
al., 1997; Guna-Dumitrescu & Pelletier, 1996; Kehle et al., 1998; Mitchell & Kratochwill, 2013; 




Careful review of these investigations reveals that an important component of successful 
SM intervention may involve the use of devices that prompt vocalization or listening to 
previously recorded vocalizations during therapy. Most common among these devices appears to 
be the use of audio recorders with which the children record their voices and play it for others to 
hear, thus following a desensitization/exposure paradigm (Blum et al., 1998; Kee et al., 2001; 
Oerbeck et al., 2011; Oon, 2010). An extension of this paradigm has included the children using 
audio devices with pre-recorded responses to answer questions that may be asked by others (e.g., 
“Yes,” “No,” “Thank you,” and “Goodbye”; Kee et al., 2001). Additionally, and following the 
desensitization paradigm, the use of games (e.g., chutes and ladders, passing a ball back and 
forth, blowing up balloons, and melting ice pops) have been utilized to promote speaking 
behaviors during behavior therapy (Mitchell & Kratochwill, 2013; Oon, 2010; Reuther et al., 
2011; Sharkey, McNicholas, Barry, Begley, & Ahern, 2008). Other tools included internet 
delivered cognitive behavioral therapy (Fung, Manassis, Kenny, & Fiksenbaum, 2002), index 
cards indicating which words to vocalize (Giddan et al., 1997), edited and dubbed video 
recordings to simulate the children speaking to others (Kehle et al., 1998), and a car radio where 
sound was increased in volume to require the child to speak at increased voice volumes (Nolan & 
Pence, 1970). The use of activities in behavioral intervention for SM has provided an interesting 
treatment paradigm that, when coupled with today’s technology, may provide an important 
advancement in the treatment of SM. One of these activities may include the use of mobile 
applications. 
Using Mobile Applications to Treat Selective Mutism 
 Mobile devices such as tablet PCs and smartphones provide numerous free-to-use and 
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inexpensive applications, which are downloadable to the device. By having a virtually unlimited 
number of activities (e.g., games requiring verbalization, sound and video recorders, flash cards 
decibel meters, recording devices) in one compact electronic device, mobile devices may serve 
as an invaluable tool during the initial stages of treating SM. Further, many youth are familiar 
with and readily use mobile devices on a daily basis (Lenhart, 2015; Madden, Lenhart, Duggan, 
Cotesi, & Gasser, 2013). Thus, the use of mobile devices may promote both more engagement 
and a willingness to participate in treatment in addition to providing a range of electronic 
activities in one compact device. 
 Thus far, mobile applications have been used in one study (i.e., Bunnell & Beidel, 2013). 
This investigation resulted in the successful treatment of a 17-year-old female with SM who was 
previously unresponsive to pharmacological and standard behavioral intervention. Following 
limited treatment gains using traditional exposure therapy alone, the authors used mobile 
applications while rewarding successive approximations of speech. Using mobile applications 
and a shaping hierarchy, the patient was speaking in a conversational tone and using complete 
sentences at the end of the first treatment session. These results required replication. In Study 1 
we used a single case design strategy to replicate and validate the use of mobile applications as 




STUDY 1: REPLICATION AND EXTENSION 
 The primary goal of Study 1 was to replicate and extend the initial treatment success 
(Bunnell & Beidel, 2013) using a single-case design strategy. Specifically, the primary 
dependent variable in Study 1 was the time until audible speech occurred. The hypotheses for 
Study 1 were as follows: following initiation of treatment using mobile applications, children 
will a) speak audibly during the initial treatment session to at least one unfamiliar adult (i.e., the 
clinician) and b) speak audibly to the clinician and at least one other unfamiliar adult during the 






Following informed consent, children were assessed via a clinician administered 
diagnostic interview in addition to child- and parent-report measures to affirm the diagnosis of 
SM. Children and their parents were informed that the purpose of the study would be to evaluate 
the usefulness of mobile applications during the treatment of SM, and that they would play 
games on a tablet PC (i.e., an Apple iPad) with the goal of helping them to feel more comfortable 
speaking around other people. In addition to one treatment planning session, children completed 
two, 55-minute sessions conducted in the same week. This investigation focused solely on the 
ability of the mobile applications to quickly shape speaking behavior. All assessment and 
treatment sessions were administered by a senior doctoral student in clinical psychology. 
Design 
 Study 1 used a single-case (A-B) design strategy, the results of which are interpreted 
graphically. This design compares baseline data to data collected following the implementation 
of treatment to determine a treatment effect via the demonstration of a clear change from 
baseline. In Study 1, the treatment planning session served as a baseline for the assessment of 
speech to unfamiliar adults. In addition, subjective anxiety was assessed during baseline as well 
as the treatment sessions. 
Participants 
 Participants were four children who met DSM-5 (APA, 2013) criteria for SM. Children 
ranged in age from 6- to 10-years. Children 1 and 2 were Latina female sisters (ages 9 and 10-
years, respectively) who had not spoken to non-family members since 5-years of age. Both 
children refused speech to peers and staff at school, and reported elevated levels of social anxiety 
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as the reason for their withdrawal of speech. Child 3 was a 7-year old Latino male who refused 
speech to non-family members since 4-years of age, with the exception of whispers to one 
teacher and one peer approximately twice per week. Although his mother perceived him as 
experiencing elevated levels of social anxiety, Child 3 did not report significant elevations in 
anxiety as the reason for his speech withdrawal. Child 4 was a 7-year old Caucasian female who 
refused speech to non-family members since 3-years of age, with the exception of whispers to 
one peer at school approximately once per day. All children refused speech to extended family 
members within and outside of their home. Exclusionary criteria included potential comorbid 
severe psychopathology (i.e., bi-polar disorder, schizophrenia) and/or suicidal ideation. Children 
with other co-morbid diagnoses were not excluded and none of the children were taking anti-
depressant medications during the time of the study. See Table 1 for participant demographics 
and child- and parent-reported assessment results. 
Table 1 Participant Demographic and Assessment Data 
Child Age Sex Race SPAI-C SPAIC-PV 
1 9 F Latino 37 33 
2 10 F Latino 35 31 
3 7 M Latino 2 24 
4 7 F Caucasian 23 26 
Note. SPAI-C = Social Phobia and Anxiety Inventory for Children; SPAIC-PV = Social Phobia 
and Anxiety Inventory for Children – Parent Version; Scores ≥ 18 on the SPAI-C and SPAIC-PV 
reflect clinically elevated levels of social anxiety. 
 
Assessment 
 Diagnostic interview. The Anxiety Disorders Interview Schedule for DSM-IV: Child 
and Parent Versions (ADIS-C/P; Silverman and Albano, 1996) are semi-structured interviews 
used for the diagnosis of anxiety and related disorders in youth. The ADIS-C/P provides a 
diagnosis based on both child- and parent-report, although the assessment of child functioning 
relied mostly on parent-report in the current study. If children responded to questions during the 
10 
 
interview, it was by nodding their head.  
 Child social anxiety. Children and their parents completed the Social Phobia and 
Anxiety Inventory for Children (SPAI-C; Beidel, Turner, & Morris, 1995) and the SPAI-C 
Parent Version (SPAIC-PV; Beidel, Turner, & Morris, 2004). The SPAI-C and SPAIC-PV 
consist of 26 items that assess the frequency of anxiety symptoms during particular social 
situations. Participants rate each item using three ordered responses: 0 = Never, or Hardly Ever, 
1 = Sometimes, and 2 = Most of the Time or Always. The SPAI-C and SPAIC-PV have 
demonstrated adequate reliability and validity (Beidel et al., 1995; Beidel, Turner, Hamlin, & 
Morris, 2000; Higa, Fernandez, & Nakamura, 2006) 
 Behavioral Assessment. Children’s within-session speaking behaviors and anxiety were 
recorded digitally by the clinician. The number of persons to whom the children spoke during 
each session as well as the children’s latency to speak to the clinician and additional adults was 
recorded digitally and counted. Children were prompted to rate their current anxiety level on a 5-
point Likert-scale (0 = No Anxiety; 1 = Mild Anxiety; 2 = Moderate Anxiety; 3 = Severe 
Anxiety; 4 = Extreme Anxiety) every ten minutes during baseline and both treatment sessions. 
Treatment 
 Following assessment, children and their parents participated in a treatment planning 
session during which the treatment rationale was presented, and a contingency management plan 
to increase speaking behaviors was established. Specifically, children were told that they would 
earn $10 of monopoly money to spend on prizes for each compliant response during sessions. 
Further, children would receive rewards from their parents (e.g., extra dessert, staying up 30-
minutes past bedtime) following each treatment session during which they complied with 
clinician requests.  
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 Children then completed two, 55-minute sessions administered within the same week. 
During session 1, children were rewarded for successive approximations of speech while using 
mobile applications. During the second session children were rewarded for approaching and 
speaking to multiple other unknown adults around the University campus, which consisted 
mostly of asking open-ended questions. All children followed the same shaping hierarchy, 
including the same mobile applications at each step in treatment, with some minor variation 
during the second session (see Table 2 for the specific shaping hierarchy). 
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Table 2 Mobile Applications Used During Each Session 
Session Step Mobile Application Behavior to Emit Treatment Goal 
1 1 Free Candle Blow out candle once Emit audible sound 
  2 Free Candle Blow out candle with increased pressure Emit audible sound at increased volume 
  3 Free Candle Blow out candle at increased frequency (≤5) Emit multiple audible sounds at increased volume 
  4 Blowing Game Blow ants off of a virtual picnic table loudly Emit multiple audible sounds at increased volume 
  5 Yes/No Fun Deck Blow in response to close-ended questions Emit audible sounds while responding to questions 
  6 Talking Gina Blow “O” sounds Begin to emit audible verbalizations 
  7 Talking Gina Blow “U” sounds Continue to emit audible verbalizations 
  8 Talking Gina Blow vowel sounds Increase the number of audible verbalizations 
  9 Meet the Vowels Whisper vowels Continue to practice emitting audible verbalizations 
  10 Meet the Letters Whisper letters including consonants Increase the number of audible verbalizations 
  11 Meet the Words Whisper words Begin to verbalize words 
  12 Meet the Words Speak words with increased volume Increase the volume of verbalized words 
  13 Camstar Say the names of items photographed Generalize speaking to items rather than written words 
  14 Yes/No Fun Deck Say yes or no to questions asked Respond verbally to close-ended questions 
  15 Monsters Record and play responses to open ended questions Respond verbally to open-ended questions 
  16 Monsters Record and play open ended questions asked by the 
child directed toward therapist 
Verbalize questions for others to answer 
2 1 Monsters* Record and play open ended questions asked by the 
child directed toward others in the room 
Verbalize questions for others to answer 
  -- SPLDecibel Meter Ask open ended questions while maintaining a 
designated volume 
Verbalize questions for others to answer at increased 
volume 





Within-session speaking. Figure 1 displays the number of adults to whom each child 
spoke during each session. All children withheld speech during the treatment planning session. 
All children spoke to the clinician during the first session, and child 3 spoke to six adults in 
addition to the clinician during the first session. As displayed in Figure 1, children spoke to a 
range of 7 to 19 adults during the second session (M = 13). This number depended on the 
availability of adults with whom children could speak as well as the time allotted for each 
session, but of note is that children approached and spoke with all adults with whom they were 
instructed to initiate conversation. 
 
Figure 1 Number of Adults Spoken to During Each Session 
 
Within-session latency to speak. As demonstrated in Table 3, all children whispered to 
the clinician within 31 minutes of the first session and all children spoke in a conversational tone 
within 40 minutes of the first session. Further, all children spoke to an adult other than the 
































Table 3 Within-Session Latency to Speak 
Child  Session 1  Session 2 
  Time to Whisper to 
Clinician 
 Time to Speak Audibly to  
Clinician 
 Time to Speak to an 
Additional Adult 
Child 1  30.00  40.06  13.44 
Child 2  31.20  39.38  12.53 
Child 3  19.29  27.39  * 
Child 4  19.97  32.30  5.00 
Note. * = Child 3 spoke to an additional unfamiliar adult within 50 minutes of the first session; 
time is measured in minutes. 
 
Within-session anxiety. As demonstrated in Figure 2, all children reported mild to 
moderate levels of anxiety during the first two sessions, with the exception of child 3 who 
reported ratings of 0 for both sessions.  
 
Figure 2 Within-Session Anxiety Ratings  





















































 The goal of Study 1 was to determine whether the use of mobile applications during the 
shaping of verbal behaviors could enhance verbal responding in children with SM. When 
compared to the extant literature and clinical experience, the results of Study 1 suggest that, 
when used in conjunction with rewarding successive approximations of speech, the use of mobile 
applications may decrease the time and clinical effort necessary to achieve a significant 
milestone in the treatment of children with SM, that is, to achieve the goal of speaking to a non-
family member in a public setting. All children spoke to an unfamiliar adult (i.e., the clinician) 
during the first treatment session. All children spoke to the clinician audibly within 40 minutes of 
the first treatment session. All children also spoke audibly to the clinician and at least one other 
unfamiliar adult during the second treatment session (children spoke to an average of 13 adults 
during this session) and did so within the first 14 minutes of the second treatment session. These 
rapid treatment gains are highly encouraging given that children in this study had not spoken to 
unfamiliar adults or peers before beginning treatment.  
 There are limitations of Study 1; predominantly a lack of comparison to children treated 
using the identical shaping protocol but without the use of mobile applications. Another 
limitation not addressed in Study 1, but which might be addressed in an additional investigation 
is a lack of understanding of the exact mechanisms by which the changes occurred. More 
specifically, it is unknown why such rapid treatment gains were made during this study. It is 
possible that the engagement of the mobile device served to decrease the child’s anxiety allowing 
them to more fully engage in the shaping process (Bunnell & Beidel, 2013). The authors 
suggested that “using tasks that require vocalization but engage children in reinforcing game-like 
activities may shift direct focus away from speaking, which in turn could decrease social anxiety 
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and thereby allow speech to occur” (pp. 292). In other words, it is possible that reciprocal 
inhibition, the process that underlies desensitization (Wolpe, 1954, 1958, 1961; Wolpe & 
Lazarus, 1966), may allow for faster treatment gains in children with SM. This explanation 
seems likely given the minimal anxiety reported by the children during these initial sessions. 
Anecdotally, when asked why they were not anxious, all children reported, “because I was 
having fun”. It may be possible to test this hypothesis by examining children’s physiological 
anxious arousal during treatment using mobile applications, while comparing this reactivity to 




STUDY 2: MECHANISMS OF CHANGE DURING TREATMENT: INTRODUCTION 
Systematic Desensitization 
 Systematic desensitization was one of the earliest behavioral interventions for anxiety 
disorders, particularly specific phobias (Wolpe, 1954, 1958, 1961; Wolpe & Lazarus, 1966). 
According to Wolpe, systematic desensitization involves the use of a competing response that 
interferes with a response pattern which is considered “unadaptive”. Theoretically, unadaptive 
responses (e.g., anxiety) are eliminated through use of the counter conditioning paradigm (Jones, 
1924), which postulates that a conditioned stimulus’ ability to elicit a conditioned response is 
lost if the conditioned stimulus is paired with a new stimulus that elicits a response incompatible 
with the original conditioned response. For this process to occur, the incompatible response must 
be “stronger” than the original conditioned response (Wolpe, 1968). The pairing of this 
incompatible response is believed to inhibit the original conditioned response, which is 
weakened over time. Because of the bi-directionality of each stimulus’ ability to inhibit the other, 
Wolpe termed this process “conditioned inhibition based upon reciprocal inhibition” (Wolpe, 
1968). Based on these laboratory findings Wolpe introduced the intervention known as 
systematic desensitization, which involves the gradual exposure to feared stimuli while 
simultaneously conditioning a response that is incompatible with fear (e.g., typically relaxation 
or feelings of happiness). This differs from other types of exposure therapy, which are based on 
an extinction model and involve the use of exposure to feared stimuli without the use of a 
competing response. Systematic desensitization is used widely in the treatment of anxiety 
disorders. 
 In theory, a systematic desensitization/reciprocal inhibition paradigm might explain the 
rapid treatment gains observed when using the mobile applications. Pairing an emotion 
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incompatible with anxiety during a distressful situation (i.e., interaction with a stranger) will 
eliminate fearful responses in those settings, which in turn should allow speech to occur. Based 
on the minimal levels of child-reported anxiety observed in these two studies, this seems likely, 
but confounds arise when using solely child-reported anxiety (e.g.,). Adding the direct 
assessment of anxious arousal during treatment using measures such as heart rate variability 
(HRV; i.e., inter-beat interval) and electrodermal activity (EDA; also known as galvanic skin 
conductance) would help to clarify the mechanism by which mobile applications seem to exert 
their effect, particularly by comparing autonomic arousal to that of children treated with behavior 
therapy (i.e., without the use of mobile applications). 
HRV is the variation between heart beats (i.e., the inter-beat-interval), and is an indicator 
of autonomic regulation or flexibility (i.e., the interplay between sympathetic and 
parasympathetic activation; Billman, 2011). Increases in HRV occur when individuals are in a 
calm or relaxed state, which is indicative of increased parasympathetic activity. Conversely, 
decreases in HRV are observed when an individual is experiencing high levels of distress such 
that parasympathetic activity is inhibited (e.g., a “fight or flight” response). These trends have 
been noted particularly as individuals attempt to regulate their emotions during stressful social 
interactions (Porges, 2007). Similarly, EDA is a direct measure of sympathetic activation and 
elevations in EDA are observed in youths with elevated social anxiety during socially-distressing 
interactions (e.g., Mesa, Beidel, & Bunnell, 2014). 
 Thus, the goal of Study 2 is to examine children’s physiological arousal during shaping 
procedures, with and without the use of mobile applications. The hypotheses of Study 2 were 
that, when compared to children shaped with reinforcement alone and children shaped using 
other therapeutic activities, children shaped with the use of mobile applications would a) 
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complete the shaping hierarchy earlier in the session, b) speak earlier in the session, c) report 
lower levels of anxiety during treatment, and d) exhibit lower levels of physiological anxious 






 Following informed consent and assent, children and their parents participated in a 
diagnostic assessment and completed questionnaires assessing child- and parent-report of social 
anxiety. Children were informed that the purpose of the study would be to help them to feel more 
comfortable speaking around other people. Children and their parents were also educated on the 
use of physiological monitoring equipment, the rationale behind the procedure, and contingency 
management procedures which included rewards of $10 of monopoly money for each compliant 
response during sessions to be spent on prizes at the end of the session in addition to rewards 
from parents between sessions. Children were then assigned randomly to one of three behavioral 
therapy groups: children shaped to emit audible speech including the use of mobile (i.e., Apple 
iPad) applications (iBT), children shaped using other similar activities (aBT), or children shaped 
with reinforcement alone (BT). A Microsoft Excel formula for random number generation was 
use to assign children to their respective groups. Following assessment and randomization, 
children participated in two sessions, conducted within the same week. Physiological arousal was 
assessed during these sessions. Outcome data included children’s time to completion of the 
shaping hierarchy, latency to speak to the clinician and an additional adult, self-reported anxiety, 
and physiological measures of anxious arousal (as measured by HRV and EDA). Assessment and 
treatment sessions were administered by two senior doctoral students in clinical psychology, and 
sessions were video and audio-recorded. 
Design 
 Study 2 used a single case (A-B) design with comparisons of child speaking behaviors, 
self-reported anxiety, and physiological anxious arousal among the iBT, aBT and BT groups. 
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Children were asked to sit quietly for five minutes at the beginning of each session to establish a 
baseline level of anxious arousal during both treatment sessions. Following this baseline phase, 
the treatment phase began and data collection continued. 
Participants 
Participants included 15 (n = 5 per group) children who met DSM-5 (APA, 2013) criteria 
for SM. Participants ranged in age from 5 to 17 years. Exclusionary criteria included children 
with severe psychopathology (i.e., bi-polar disorder, schizophrenia) and/or suicidal ideation. 
Participants with other co-morbid diagnoses were not excluded. Participants taking anti-
depressant medications during the time of the study were included as long as they had been on a 
stable dose for at least one month prior to beginning treatment. It should be noted that Child 5 in 
the BT group presented with a unique case of SM and SAD such that her withdrawal of speech 
and social fears were specific to speaking to adults, particularly while in the presence of her 
parents, thus her scores on the SPAI-C and SPAIC-PV both fell below the cutoff for a probable 
diagnosis of SAD. Despite this, the child and her parents insisted that social anxiety was the 
driving factor behind her withdrawal of speech. Similarly, Child 2 in the iBT group reported low 
levels of social anxiety on the SPAI-C, although his parents felt that his lack of speech was 
largely associated with social anxiety, as demonstrated by his elevated SPAIC-PV score. 








Table 4 Participant Demographic, Diagnostic, and Social Anxiety Severity Data 
 Age Sex Race Diagnoses SPAI-C SPAIC-PV 
iBT Group 
Child 1 9 M White SM, SAD 23 14 
Child 2 16 M White SM, SAD, SepAnx 9 40 
Child 3 13 F White SM, SAD 41 33 
Child 4 9 F White SM, SAD, GAD 38 43 
Child 5 6 F Latina SM, SAD 16 16 
aBT Group 
Child 1 10 F White SM, SAD 41 38 
Child 2 5 M Latino SM, SAD 46 46 
Child 3 16 F Latina SM, SAD 28 43 
Child 4 11 F White SM, SAD 39 42 
Child 5 5 F Latina SM, SAD, Enuresis 38 36 
BT Group 
Child 1 15 F Latina SM, SAD 44 45 
Child 2 5 M Black SM, SAD, SepAnx 36 40 
Child 3 8 M White SM, SAD, Enuresis 30 28 
Child 4 7 F White SM, SAD 30 41 
Child 5 9 F White SM, SAD 13 14 
Note. SM = Selective Mutism; SAD = Social Anxiety Disorder; SepAnx = Separation Anxiety 
Disorder; GAD = Generalized Anxiety Disorder; iBT = group shaped using mobile applications; 
aBT = group shaped using other therapeutic activities; BT = groups shaped using no activities; 
SPAI-C = Social Phobia and Anxiety Inventory for Children; SPAIC-PV = Social Phobia and 
Anxiety Inventory for Children – Parent Version; Scores ≥ 18 on the SPAI-C and SPAIC-PV 
reflect clinically elevated levels of social anxiety. 
Assessment 
 Diagnostic interview. The ADIS-C/P was administered to children and their parents 
simultaneously. Children were not asked to speak during this interview although they were asked 
to nod their heads (yes or no) to indicate whether they agreed with their parents’ response to 
particular questions. If disagreements took place, children would whisper to their parent and 
child and parent would compromise on an appropriate response. Children did not speak to the 
clinician during the assessment session.  
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 Child and parent report of social anxiety. Children and their parents completed the 
SPAI-C and SPAIC-PV. For younger children who experienced difficulty with reading, parents 
assisted in reading SPAI-C questions. 
Behavioral assessment. Each child’s latency to complete the shaping hierarchy during 
the first session, and latency to speak to the clinician and an additional unfamiliar adult (during 
the second session) was recorded and coded using the Noldus Behavioral Observation System 
XT (Noldus Information Technology, 2015) and comparisons were made amongst groups. 
Children reported their current level of anxiety using a 5-point Likert scale following the 
baseline period and every five minutes during sessions.  
Physiological assessment of anxious arousal. Physiological anxious arousal (i.e., HRV 
and EDA) was measured using the Mindware BioLab Acquisition Software and Ambulatory 
System (Mindware Technologies, LTD, 2009). This ambulatory equipment allows for the 
simultaneous collection of data continuously (i.e., approximately 500 samples per second) via a 
small ambulatory unit, which transmits data wirelessly to be stored digitally for subsequent 
analysis. These data are then examined juxtaposed to a synced video recording of the treatment 
sessions using the Noldus Behavioral Observation System XT (Noldus Information Technology, 
2015). Anxious arousal relative to baseline levels was then calculated and compared amongst 
groups. 
Treatment 
 All children were shaped using the hierarchy described in Table 5 with the iBT group 
including the use of mobile applications (see column 3), the aBT group including the use of other 
activities which were similar to each step’s respective mobile application (e.g., bubbles, 
pinwheels, flash cards, sound recorders; see column 4), and the BT group following the 
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hierarchy without the inclusion of activities or devices (see column 5). Children remained in the 
session until completion of the hierarchy. In two cases (i.e., iBT Child 3 and aBT Child 2) this 
was not possible due to variable consistency in the children’s level of response to requests from 
the clinician, and the eventual withdrawal of compliant responses. Thus, data from these two 
children were not analyzed. Children were rewarded with $10 of monopoly money for each 
compliant response during sessions. This monopoly money was added at the end of the session 
and spent on prizes (e.g., small toys and stickers) at the clinic, and also counted toward a reward 
from the child’s parent following the session (e.g., money towards a game or toy). They were 
rewarded for successive approximations of speech during the first session, and were required to 
complete each step of the hierarchy successfully a minimum of five times to advance to the next 
step.  The protocol for the second session included five, five-minute conversations with 
unfamiliar adults during which children were rewarded each time they spoke to the adult. During 
this process, children asked the adult an open-ended question, which the adult answered, and 
then asked the same question to the child. This process continued, alternating between the adult 
and the child initiating the initial questions for a total of five minutes. During session 2, children 
in the iBT and aBT groups began with the use of the mobile device or voice recorder (see Table 
5), but were allowed to continue conversations without the use of the device if they felt 








Other Tool Behavior to Emit Treatment Goal 
1 1 Free Candle Blow Bubbles Blow once Emit audible sound 
  2 Free Candle Blow Bubbles Blow with increased pressure Emit audible sound at increased volume 
  3 Free Candle Blow Bubbles Blow at increased frequency (≤5) Emit multiple audible sounds at increased volume 
  4 Blowing Game Pinwheel Blow loudly and repeatedly Emit multiple audible sounds at increased volume 
  5 Yes/No Fun Deck Yes/No Flashcards Blow in response to close-ended 
questions 
Emit audible sounds while responding to 
questions 
  6 Talking Gina Voice Recorder Blow “O” sounds Begin to emit audible verbalizations 
  7 Talking Gina Voice Recorder Blow “U” sounds Continue to emit audible verbalizations 
  8 Talking Gina Voice Recorder Blow vowel sounds Increase the number of audible verbalizations 
  9 Meet the Vowels Flash Cards Whisper vowels Continue to practice emitting audible 
verbalizations 
  10 Meet the Letters Flash Cards Whisper letters including consonants Increase the number of audible verbalizations 
  11 Meet the Words Flash Cards Whisper words Begin to verbalize words 
  12 Meet the Words Flash Cards Verbalize words with increased volume Increase the volume of verbalized words 
  13 Camstar Disposable Camera Say the names of items photographed Generalize speaking to items rather than written 
words 
  14 Yes/No Fun Deck Yes/No Flashcards Say yes or no to questions asked Respond verbally to close-ended questions 
  15 Monsters Voice Recorder Respond to open ended questions Respond verbally to open-ended questions 
  16 Monsters Voice Recorder Ask and respond to open ended 
questions 
Verbalize questions for others to answer 
2 1 Monsters Voice Recorder Ask and respond to open ended 
questions with additional adults 
Verbalize questions for others to answer 





Session recordings and physiological data were imported into Noldus Observer XT 
observation software (Noldus Information Technology, 2015). Baseline and treatment phases 
were coded as well as time until completion of the shaping hierarchy, children’s latency to speak 
to the clinician (operationalized as either whispering or saying a complete word), and latency to 
speak to an additional unfamiliar adult. These data were then compared descriptively among 
groups. Children’s self-reported anxiety was recorded in-session by the clinician and change 
scores were calculated by averaging scores across the treatment phase and subtracting this 
average from baseline ratings. Children’s anxiety ratings at the time of first speech to the 
clinician were also recorded and compared among groups. HRV (i.e., inter-beat interval) and 
EDA (i.e., skin conductance level in microsiemens) were averaged for each minute of each 
session. 
Small n Statistics software (Gilroy, 2015) was used to compare baseline and treatment 
HRV and EDA data for each participant using the following evidence-based metrics for single 
case research. The Percentage of All Non-Overlapping Data statistic (PAND; Parker, Hagan-
Burke, & Vannest, 2007) measures the percentage of all data points that do not overlap between 
baseline and treatment. Hedge’s g* (Hedges, 1981) is an effect size measure with additional 
adjustment for the upward bias of smaller sample sizes (i.e., does not assume equal variances). 







Hierarchy completion and speaking behavior. Thirteen of 15 children (86.67%) 
completed the shaping hierarchy during the first session. Children’s latency to complete the 
hierarchy ranged from 14 to 54 minutes (M = 31.21, SD = 12.62). The average latency to 
complete the hierarchy for children in the iBT group (M = 27.69, SD = 6.84) was approximately 
3 to 7 minutes shorter in comparison to those in the aBT (M = 35.65, SD = 9.23) and BT (M = 
31.79, SD = 17.82) groups, respectively.  
All children, regardless of group spoke to the clinician within 22 minutes of the first 
session. The average latency to speak to the clinician for all groups fell between 10.56 and 13.68 
minutes, a range of approximately three minutes. This latency was slightly higher for children in 
the iBT group. All children spoke to an additional unfamiliar adult within 97.76 seconds of being 
prompted to do so during the second session. The average latency for each group ranged from 
23.43 to 36.09 seconds. All children participated in the planned five, five-minute conversations 




Table 6 Behavioral Assessment of Hierarchy Completion and Speaking Behavior 
 
Latency to Hierarchy 
Completion (in minutes) 
Latency to Speak to the 
Clinician (in minutes) 
Latency to Speak to 
Additional Adult 
During Second Session  
(in seconds) 
iBT Group 
Child 1 37.81 22.05 11. 80 
Child 2 25.86 13.48 14.54 
Child 3 - - - 
Child 4 23.55 5.04 20.29 
Child 5 23.53 14.15 97.76 
M (SD) 27.69 (6.84) 13.68 (6.98) 36.09 (46.48) 
aBT Group 
Child 1 37.36 11.23 18.35 
Child 2 - -  - 
Child 3 22.32 8.18 44.05 
Child 4 39.52 11.00 73.47 
Child 5 43.40 16.05 3.77 
M (SD) 35.65 (9.23) 11.61 (3.27) 34.91 (30.63) 
BT Group 
Child 1 54.19 10.80 13.75 
Child 2 47.35 20.08 29.59 
Child 3 19.02 6.95 25.06 
Child 4 23.99 8.83 23.86 
Child 5 14.41 6.17 24.89 
M (SD) 31.79 (17.82) 10.56 (5.61) 23.43 (5.84) 
Note. M = Mean; SD = Standard Deviation. 
Child-reported anxiety. With respect to self-reported levels of anxiety, children in the 
iBT group tended to report lower and less varied ratings of anxiety for both sessions. The 
average rating during the first session for children in this group was 1.57 (SD = 0.74), compared 
to 2.67 (SD = 0.89) and 2.20 (SD = 1.22) for the aBT and BT groups, respectively. The average 
rating during the second session for children in the iBT group was 1.46 (SD = 0.60), compared to 
2.54 (SD = 1.30) and 1.64 (SD = 1.12) for the aBT and BT groups, respectively. All children in 
the iBT group reported moderate and below moderate levels of anxiety (≤ 3), whereas children in 
the aBT and BT groups reported maximum ratings between 4 and 5.  
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With respect to individual ratings of anxiety, four children (two in the aBT group and two 
in the BT group) reported anxiety ratings above baseline levels during the first session. Children 
in the iBT group did not report ratings above their initial baseline anxiety ratings during this 
session, suggesting no increase in anxiety as a result of treatment demands to begin speaking. 
During session 2, a similar pattern was observed with the exception that one child in the iBT 
group reported ratings above baseline, although it should be noted that the child from this group 
was the only child to return back to baseline levels by the end of the session. 
Children’s anxiety ratings during each session were averaged and subtracted from 
baseline anxiety ratings, with positive and negative values indicating average increases and 
decrease from baseline, respectively. One child in the aBT group and one child in the BT group 
exhibited average increases in anxiety from baseline during session 1. In contrast, all other 
children exhibited either average decreases or no average change in anxiety from baseline. On 
average, each group exhibited mean decreases in anxiety from baseline, with the iBT group 
demonstrating the largest decrease, and the aBT and BT groups following in suit. Group 





Figure 3 Average Self-Reported Anxiety Ratings in Relation to Baseline Ratings for Session 1 
  
In contrast to session 1, average decreases in anxiety from baseline were not observed for 
session 2. Only one child in the iBT group exhibited an average increase from baseline, whereas 
two children from the aBt and BT groups exhibited increases. On average, each group exhibited 
mean increases in anxiety from baseline. A similar pattern to session 1 was observed such that 
the iBT group demonstrated the smallest average increase with the aBT and BT groups following 
in suit. Group differences were more pronounced for this session and once again followed the 









































































































































Figure 4 Average Self-Reported Anxiety Ratings in Relation to Baseline Ratings for Session 2 
 
 Anxiety ratings were recorded at the time of each child’s first audible word to the 
clinician during the first session. As demonstrated in Figure 5, following initial speech to the 
clinician, children in the iBT group reported the lowest ratings of anxiety (M = 1.5, SD = 0.58) in 
comparison to the aBT (M = 2.5, SD = 0.58) and BT (M = 2.2, SD = 1.30) groups. 
 






























































































































































































































































Physiological assessment of anxious arousal. Comparisons of HRV among children in 
the three treatment groups followed similar patterns to self-report of anxiety, yet comparisons of 
EDA and did not yield consistent results for groups across sessions. 
HRV Session 1. Results of analyses of HRV concurred with self-reported anxiety. 
Specifically, children in the iBT group tended to exhibit fewer changes in HRV from baseline. 
From baseline measures, mean HRV decreased by 0.51 and 0.92 standard deviations for children 
in the aBT and BT groups, respectively, indicating increased sympathetic (i.e., “fight or flight”) 
responding. Conversely, children in the iBT group showed average 0.05 standard deviation 
increase in HRV from baseline, indicating parasympathetic activation (e.g., recovery after a 
“fight or flight” response). Non-overlap effect size indices concurred with these results with 
children in the iBT group demonstrating the least non-overlap in HRV between baseline and 
treatment phases (i.e., 66.10% vs. 83.80% and 72.65% for the aBT and BT groups, respectively). 
The iBT group’s change in HRV from baseline also accounted for a smaller proportion of the 












Table 7 Comparisons in HRV among Participants for Session 1 
 M (SD)Baseline M (SD)Treatment Hedge’s g* PAND r2 
iBT Group 
Child 1 759.22 (21.17) 744.24 (46.76) -0.30 56.25 0.03 
Child 2 1193.64 (69.59) 1068.21 (115.70) -1.02 87.88 0.25 
Child 3 - - - - - 
Child 4 703.14 (45.46) 728.16 (84.89) 0.28 37.50 0.02 
Child 5 618.70 (24.72) 658.81 (30.22) 1.23 82.76 0.33 
Mean 818.68  (40.23) 799.86 (69.39) 0.05 66.10 0.16 
aBT Group 
Child 1 677.24 (17.80) 645.32 (26.86) -1.10 85.18 0.28 
Child 2 - - - - - 
Child 3 684.01 (21.08) 706.30 (38.22) 0.55 75.86 0.09 
Child 4 925.97 (17.04) 851.31 (32.37) -2.15 95.74 0.60 
Child 5 611.28 (10.67) 629.26 (24.84) 0.67 78.43 0.13 
Mean 724.63 (16.65) 708.05 (30.57) -0.51 83.80 0.27 
BT Group 
Child 1 836.44 (31.94) 794.18 (45.10) -0.86 60.00 0.19 
Child 2 702.64 (17.17) 717.53 (32.10) 0.43 67.27 0.05 
Child 3 674.08 (10.84) 658.76 (18.00) -0.81 74.07 0.18 
Child 4 576.14 (14.32) 515.90 (18.06) -3.09 100.00 0.76 
Child 5 671.98 (17.99) 663.31 (29.90) -0.28 61.90 0.02 
Mean 692.26 (18.45) 669.94 (28.65) -0.92 72.65 0.24 
Note. PAND = percentage of all non-overlapping data.  
 
HRV Session 2. Children in the iBT group demonstrated the least non-overlap in HRV 
between baseline and treatment phases (i.e., 59.35% vs. 70.00% and 81.83% for the aBT and BT 
groups, respectively), suggesting the least change from baseline for this group during session 2. 
However, the results of the Hedge’s g* effect size estimates suggested that the aBT group 
exhibited the smallest decrease in HRV (Hedge’s g* = -0.29), followed by the iBT (Hedge’s g* 
= -0.78), and BT (Hedge’s g* = -1.05) groups. Little difference was noted for the variance 
accounted for changes in HRV from baseline between the iBT and aBT groups (r2s = 0.17 and 
0.19, respectively), although the BT group’s change from baseline accounted for a large portion 





Table 8 Comparisons in HRV among Participants for Session 2 
 M (SD)Baseline M (SD)Treatment Hedge’s g* PAND r2 
iBT Group 
Child 1 815.53 (24.43) 777.05 (36.14) -0.99 63.89 0.24 
Child 2 1011.93 (66.49) 980.17 (43.61) -0.61 47.06 0.11 
Child 3 - - - - - 
Child 4 725.54 (40.36) 685.97 (28.37) -1.18 70.59 0.31 
Child 5 700.69 (6.86) 691.66 (24.92) -0.35 55.88 0.04 
Mean 813.42 (34.53) 783.71 (33.26) -0.78 59.35 0.17 
aBT Group 
Child 1 678.74 (9.07) 661.94 (10.34) -1.49 79.41 0.42 
Child 2 - - - - - 
Child 3 698.09 (21.64) 685.18 (22.19) -0.53 73.68 0.08 
Child 4 827.52 (22.28) 820.76 (32.90) -0.19 57.50 0.01 
Child 5 584.36 (9.34) 598.02 (12.00) 1.05 69.44 0.26 
Mean 697.18 (15.58) 691.47 (19.36) -0.29 70.00 0.19 
BT Group 
Child 1 953.50 (13.81) 892.02 (22.98) -2.50 97.56 0.67 
Child 2 676.86 (24.60) 715.32 (33.48) 1.07 75.00 0.27 
Child 3 697.68 (31.51) 660.70 (16.63) -1.80 88.89 0.51 
Child 4 583.71 (25.37) 553.41 (11.59) -1.91 94.77 0.54 
Child 5 738.74 (25.05) 719.70 (15.79) -0.10 52.94 0.24 
Mean 730.10 (24.07) 708.23 (20.09) -1.05 81.83 0.44 
Note. PAND = percentage of all non-overlapping data.  
 
EDA Session 1. Results of analyses of EDA for session 1 were mixed. Children in the 
iBT group demonstrated the least non-overlap in EDA between baseline and treatment phases 
(i.e., 86.46% vs. 91.10% and 99.26% for the aBT and BT groups, respectively), suggesting the 
smallest increase from baseline for this group. The results of the Hedge’s g* effect size estimates 
suggested that the aBT group exhibited the smallest increase in EDA (Hedge’s g* = 2.96), 
followed by the iBT (Hedge’s g* = 3.25), and BT (Hedge’s g* = 4.11) groups. The variance 
accounted for in changes in EDA from baseline followed a similar pattern (see Table 9). Overall, 
the iBT and aBT groups appeared most similar in response with respect to EDA, with the BT 




Table 9 Comparisons in EDA among Participants for Session 1 
 M (SD)Baseline M (SD)Treatment Hedge’s g* PAND r2 
iBT Group 
Child 1 17.91 (1.40) 19.40 (1.06) 1.23 45.83 0.32 
Child 2 4.02 (0.13) 6.51 (0.42) 5.66 100.00 0.91 
Child 3 - - - - - 
Child 4 2.67 (0.14) 6.39 (0.95) 3.75 100.00 0.82 
Child 5 5.60 (0.82) 9.58 (1.59) 2.36 100.00 0.64 
Mean 7.55 (0.62) 10.47 (1.00) 3.25 86.46 0.67 
aBT Group 
Child 1 4.80 (0.74) 6.60 (1.15) 1.45 87.04 0.40 
Child 2 - - - - - 
Child 3 5.45 (0.53) 6.37 (0.95) 1.73 79.31 0.22 
Child 4 8.04 (3.27) 17.5 (1.14) 5.85 100.00 0.91 
Child 5 9.90 (0.60) 12.64 (0.89) 2.83 98.04 0.72 
Mean 7.05 (1.28) 10.78 (1.03) 2.96 91.10 0.56 
BT Group 
Child 1 6.70 (1.19) 14.44 (1.32) 5.30 100.00 0.90 
Child 2 7.17 (0.65) 11.90 (1.61) 2.73 100.00 0.92 
Child 3 11.43 (1.30) 14.57 (0.77) 3.23 96.29 0.77 
Child 4 13.42 (0.55) 15.96 (0.58) 3.98 100.00 0.84 
Child 5 12.73 (0.36) 15.05 (0.40) 5.31 100.00 0.90 
Mean 10.29 (.81) 14.38 (0.93) 4.11 99.26 0.86 
Note. PAND = percentage of all non-overlapping data.  
 
EDA Session 2. Changes in EDA for the second session were inconclusive with all 
children exhibiting elevated levels of physiological responding. No overlap in levels of EDA 
between baseline and treatment phases were observed. An opposite pattern from previous 
analyses was observed such that children in the iBT group exhibited the largest increase in EDA, 
followed by the aBT and BT groups in sequentially decreasing order. These results contrasted 




Table 10 Comparisons in EDA among Participants for Session 2 
 M (SD)Baseline M (SD)Treatment Hedge’s g* PAND r2 
iBT Group 
Child 1 8.80 (0.88) 13.99 (0.35) 10.41 100.00 0.97 
Child 2 6.15 (0.13) 7.910 (0.27) 6.16 100.00 0.92 
Child 3 - - - - - 
Child 4 7.97 (2.10) 20.31 (1.58) 6.73 100.00 0.94 
Child 5 5.60 (0.82) 9.58 (1.59) 2.36 100.00 0.64 
Mean 7.13 (0.98) 12.94 (0.95) 6.41 100.00 0.87 
aBT Group 
Child 1 5.21 (0.40) 8.10 (0.45) 5.89 100.00 0.92 
Child 2 - - - - - 
Child 3 4.28 (0.67) 6.92 (0.61) 3.86 100.00 0.83 
Child 4 9.79 (1.00) 19.95 (0.93) 7.85 100.00 0.95 
Child 5 12.39 (1.67) 19.20 (0.79) 6.54 100.00 0.93 
Mean 7.92 (0.93) 13.54 (0.69) 6.03 100.00 0.90 
BT Group 
Child 1 4.90 (1.14) 12.81 (2.62) 2.84 100.00 0.72 
Child 2 11.4 (0.51) 20.14 (1.80) 4.63 100.00 0.87 
Child 3 12.73 (0.64) 16.93 (0.38) 9.11 100.00 0.96 
Child 4 7.99 (1.06) 11.72 (1.03) 3.24 100.00 0.77 
Child 5 7.82 (0.62) 11.25 (1.13) 2.85 100.00 0.72 
Mean 8.97 (0.79) 14.57 (1.39) 4.53 100.00 0.81 






Traditionally, the treatment of SM has been a difficult and lengthy process. This may, in 
part, be due to the many barriers to treatment commonly observed within this population (e.g., 
reinforcement for not speaking in certain environments and children’s resistance to treatment). 
Behavioral intervention for SM, including contingency management, shaping, systematic 
desensitization and exposure, has evidenced the most empirical support based on meta-analytic 
review (Pionek Stone et al., 2002). Data suggest that the addition of therapeutic activities (e.g., 
games, sound recorders) also may provide some advantages to the behavioral treatment of SM, 
particularly when coupled with today’s technological advances (e.g., mobile devices such as 
tablet PCs and smartphones; Bunnell & Beidel, 2013; Bunnell, Procci, Beidel, & Bowers, in 
press). Particularly, mobile devices allow access to a wide variety of mobile applications (e.g., 
games requiring verbalization, sound and video recorders, flash cards decibel meters, recording 
devices) that may provide therapeutic value for the treatment of SM in one small, convenient 
location. In addition to convenience and applicability, the use of mobile devices may promote 
both more engagement and a willingness to participate in treatment, perhaps through systematic 
desensitization/reciprocal inhibition (Wolpe, 1968); specifically, the pairing of enjoyment or 
pleasure, rather than anxiety or fear, when speaking with a stranger. 
 The results of Study 2 largely supported the hypotheses. With respect to hierarchy 
completion of speaking behaviors during treatment, the results of Study 1 were replicated. 
Children in the iBT group completed the hierarchy earlier that children in the aBT and BT 
groups, although this difference was minor (i.e., their latency to complete the hierarchy was 3 to 
7 minutes longer in length). All children, regardless of group, spoke to the clinician within 22 
minutes of treatment. Examination of group differences revealed that the BT group demonstrated 
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the shortest latency to speak to the clinician, followed sequentially by the aBT and iBT groups, 
respectively. Perusal of session recordings revealed that this minor difference in latency was 
likely due to time spent switching between and setting up mobile applications/therapeutic 
activities as well as time spent providing instructions for each application/activity. For example, 
the average time spent instructing children in the first step in the hierarchy was 14.46 seconds for 
the BT group, whereas instruction time was 41.56 and 46.96 seconds for the aBT and iBT 
groups, respectively. Hypothetically, multiplying this instruction time for each of the nine 
changes in mobile applications/therapeutic activities would result in approximately 6 and 9 
minutes of additional instruction time throughout the protocol for the aBT and iBT groups, 
respectively.  Regardless of possible group differences, it is important to note that these 
differences are not likely to have clinical significance, especially given that the largest mean 
difference between groups for speaking to the clinician was approximately 3 minutes. All 
children also completed five, five-minute conversations with additional unfamiliar adults during 
the second treatment session. After being prompted to do so, all children began speaking initially 
to an unfamiliar adult within approximately 1.5 minutes. The average latency to speak to an 
additional adult was similar between groups.  
To our knowledge, no other study has reported the elicitation of speech within the first 
session of the treatment of SM for multiple children, particularly across such a wide age range. 
Moreover, this is the first investigation to report speech to multiple unfamiliar adults during the 
second session of treatment. Although requiring replication with a larger sample, perhaps if used 
initially in combination with other recent interventions for SM (e.g., Bergman et al. 2013, and 
Oerbeck et al. 2014), more rapid treatment progress might occur, allowing ultimately for a 
shorter length of treatment and higher cost-effectiveness. These data support the prior literature 
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(e.g., Cohan et al., 2006; Pionek Stone et al., 2002) suggesting that behavioral strategies are most 
effective in the treatment of SM, and demonstrate specifically that the use of a structured shaping 
hierarchy and specific contingency management protocol may result in early verbalization. This 
may, perhaps, occur regardless of the activities with which they are administered, although 
understanding the specific mechanisms of change during treatment is of great importance 
(Kazdin & Nock, 2003).  
 The outcome of this investigation supported the second hypothesis. In particular, children 
in the iBT group consistently reported lower and less variable levels of anxiety during each 
session when compared to children in the other groups. Their maximum rating of anxiety fell 
within the moderate range (≤ 3), whereas some children in the other two groups reported ratings 
in the severe and extreme ranges. Consistent patterns also were observed for children’s average 
anxiety ratings in relation to baseline ratings such that children in the iBT group indicated 
smaller changes in distress in both sessions when compared to children in the other groups. This 
pattern also held true when examining children’s report of anxiety following initial speech to the 
clinician (i.e., children in the iBT group reported lower levels of distress after speaking to the 
clinician for the first time). These data were consistent with those observed in Study 1, and 
suggest that children’s subjective experience of anxious responding during treatment is 
decreased when mobile applications are used, as opposed to other therapeutic activities and 
reinforcement alone.  
Given SM’s recent reclassification as an anxiety disorder in the DSM-5 (APA, 2013), and 
literature suggesting that SM may be a developmental variant of SAD (e.g., Anstendig, 1999; 
Bergman et al., 2002; Black & Uhde, 1992; Silveira et al., 2004), finding ways to engage these 
children in therapy using a treatment modality that promotes speech while eliciting limited 
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subjective anxious distress is of great importance. Granted, not all children with SM meet criteria 
for SAD, some might be better classified as anxious-communication delayed or anxious-mildly 
oppositional (Cohan, Chavira, Shipon-Blum, Hitchcock, Roesch, & Stein, 2008), and others 
might simply be exhibiting oppositional behaviors (although these findings are mixed; Viana et 
al., 2009). Despite debate over etiology and co-morbidity of the disorder, it is plausible that a 
structured and outlined shaping hierarchy and specific contingency management protocol that 
makes use of tools that cause little to no distress in these children may be of particular use as 
treatments for SM are further refined. 
 The final hypothesis was that children in the iBT group would exhibit lower levels of 
physiological anxious arousal in comparison to children in other groups. The data from the first 
session supported this hypothesis as children in the iBT group demonstrated an average standard 
deviation increase in HRV from baseline and the least non-overlap in HRV between baseline and 
treatment phases, whereas standard deviation decreases and higher non-overlap in HRV were 
noted in the aBT and BT groups. These data suggest greater regulation of anxious arousal in 
children in the iBT group when compared to children in the other groups. These results were 
partially supported by the finding that children in the iBT group once again demonstrated the 
least non-overlap between baseline and treatment phases in EDA, although effect size changes 
between baseline and treatment phases suggested some variation in responding. 
 Physiological data for the second session provided varied results, which presented some 
difficulty in interpretation. Specifically, children in the iBT group demonstrated the least non-
overlap between baseline and treatment phases for levels of HRV, but no variation in non-
overlap between phases was observed for EDA among children, regardless of group. Effect size 
indices did not concur with these findings and varied depending on the physiological measure 
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used (i.e., HRV vs. EDA). For example, effect size results suggested that children in the aBT 
group exhibited the smallest decrease in HRV relative to baseline, whereas other results 
suggested that children in the BT group exhibited the smallest increase in EDA during session 2.  
Despite somewhat mixed results, particularly in the case of EDA data, collectively the 
data suggest decreased anxious responding in the iBT group. A number of factors might explain 
some of the more ambiguous findings in this study. One factor might have been that children had 
the option of continued use of mobile applications or voice recorders during session 2 based on 
their preference, which might have led to changes in physiological anxious arousal. More 
saliently, EDA is associated with numerous emotional response patterns. These include negative 
emotions such as fear, anxiety and embarrassment, but also include positive emotions such as 
amusement, happiness, and pleasure (Kreibig, 2010). Given this confound, it may be difficult to 
differentiate between anxious and pleasurable responding (i.e., either due to enjoyment from 
activity or positively reinforcing stimuli) in these children based solely on EDA response. To 
illustrate, children using mobile applications might have experienced pleasure, resulting in 
elevated EDA levels, whereas children shaped with reinforcement alone might have experienced 
higher levels of anxious distress, also resulting in elevated levels of EDA. Despite this confound, 
self-reported anxious distress and HRV data suggested that children experience less anxious 
distress when mobile applications are included, at least during initial administration of the 
shaping hierarchy. 
The examination of HRV in addition to child-reported anxiety in this study is a particular 
strength as it allows for a more specific analysis of anxious responding, particularly in relation to 
social anxiety or distress (Porges, 2007). Specifically, the average effect size increase in HRV 
during shaping of speech for the iBT group suggests increased parasympathetic activity, or 
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plainly put, a recovery after a “fight or flight” response. These data provide initial support for the 
postulation that shaping of speech with the inclusion of mobile applications can be an effective 
strategy in working with children with SM, and that the likely mechanism of change in this 
process is counter conditioning. Moreover, although the results of this study suggest that children 
with SM respond similarly with respect to hierarchy completion and speaking behavior 
regardless of modality of delivery, there may be benefits for the clinician to use mobile 
applications in this process. For instance, having numerous therapeutic activities in one small, 
compact device might be particularly advantageous, especially as “digital technologies play an 
important role in young children’s lives, and they generally embraced them with enthusiasm and 
pleasure” (Chaudron, 2015; pp. 24). Further, mobile devices are likely to be readily available to 
clinicians across a wide range of settings (i.e., recent data suggest that approximately 78% of 
college graduates own smartphones; Smith, 2015). Perhaps the most clinically significant finding 
relates to rapid treatment gains observed as a result of using this particular shaping hierarchy, 
and data suggesting the experience of less distress while including the use of mobile 
applications. Given the commonly reported lengthy treatment requirements for SM, having an 
established procedure for reinforcing speech early in the treatment process will be of great value, 
especially during the beginning stages of treatment. 
This study has several limitations that provide opportunities for future work in this area. 
First, this study made use of a single case design strategy with a randomized assignment to 
treatment groups. Although this design was appropriate for the question at hand, a larger 
randomized controlled trial would allow for more powerful statistical comparisons. The small 
sample included in this study limited the ability to test group differences statistically. Difficulty 
with recruitment in this population is well noted with published investigations examining the 
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treatment of SM traditionally having included small samples (e.g., N = 21 and 24 for Bergman et 
al. 2013 and Oerbeck et al. 2014, respectively). Difficulty with recruiting this population is likely 
due to the low prevalence of the disorder (i.e., ≤ 1%). A second limitation which might have 
affected data from the second session was that children had the option to continue use of mobile 
applications or voice recorders based on their preference. While some children chose to continue 
using these devices, others did not, which limited consistency for this session. Third, it should be 
clearly noted that the protocol presented in this study is not intended as a comprehensive 
treatment for SM. The shaping hierarchy provided should be viewed as a useful tool during the 
initial stages of the treatment of SM; to promote speech early in treatment in hopes of decreasing 
the time needed to begin to make initial therapeutic gains. Further intervention is needed past 
these two sessions, as speaking to a clinician is unlikely to result in spontaneous speech in the 
child’s natural environment. As noted by Beidel and Turner (2007), after children with SM and 
SAD are able to consistently produce speech following behavioral shaping of verbalizations, 
they may then go on to successfully participate in continued evidence-based intervention for 
SAD (e.g., Social Effectiveness Therapy; Turner, Beidel, Cooley, Woody, & Messer, 1994) 
which aims to decrease social anxiety and increase the frequency and effectiveness of 
socialization.  Fourth, no follow-up data were collected, thus it is unclear if the rapid initiation of 
speech was maintained weeks later. 
In summary, rewarding successive approximations of speech using this shaping hierarchy 
is likely to lead to early speech production for children with SM, regardless of the modality in 
which it is delivered. Children’s experience of anxiety may be lessened with the use of 
therapeutic activities such as mobile applications and other fun games, as evidenced by 
children’s report of anxious distress and physiological data in concordance with this report. It is 
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evident that mobile applications provide some utility during the treatment of SM. Further, it is 
possible that mobile devices will demonstrate incremental utility as efforts are made to increase 
the reach and accessibility of evidence-based procedures for encouraging speech in these 
children. This reach is not likely to be limited to providers, as protocols such as the one 
described in this investigation might be used by parents and teachers, following adequate 
training, to promote generalization of speaking behaviors to the child’s natural environment. 
Future research efforts in the area of technology and the treatment of SM might focus on this 
initiative as the potential reach will be widened significantly. In truth, we are only beginning to 
understand the utility and potential of today’s technological advances to increase the quality of 
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Table 11 Comparisons in HR among Participants for Session 1 
 M (SD)Baseline M (SD)Treatment Hedge’s g* PAND r2 
iBT Group 
Child 1 79.07 (2.19) 80.96 (5.59) 0.31 56.25 0.03 
Child 2 50.40 (3.04) 56.95 (7.68) 0.81 87.88 0.18 
Child 3 - - - - - 
Child 4 85.62 (5.58) 83.32 (8.30) -0.26 37.5 0.02 
Child 5 97.10 (4.02) 91.25 (4.18) -1.27 82.76 0.35 
Mean 78.05 (3.71) 78.12 (6.44) -0.10 66.10 0.14 
aBT Group 
Child 1 88.64 (2.31) 93.13 (3.76) 1.1 85.18 0.28 
Child 2 - - - - - 
Child 3 87.78 (2.72) 85.21 (5.02) -0.49 75.86 0.07 
Child 4 64.81 (1.20) 70.58 (2.72) 1.99 95.74 0.56 
Child 5 98.18 (1.71) 95.50 (3.98) -0.63 78.43 0.11 
Mean 84.85 (1.98) 86.10 (3.87) 0.49 83.80 0.25 
BT Group 
Child 1 71.81 (2.71) 78.80 (4.50) 0.82 60 0.17 
Child 2 85.43 (2.12) 83.79 (3.86) -0.39 67.27 0.05 
Child 3 89.03 (1.42) 91.14 (2.51) 0.81 74.07 0.18 
Child 4 104.19 (2.55) 116.44 (4.16) 2.79 100 0.72 
Child 5 89.34 (2.44) 90.63 (4.07) 0.31 61.9 0.03 
Mean 87.96 (2.45) 92.16 (3.82) 0.87 72.65 0.23 




Table 12 Comparisons in HR among Participants for Session 2 
 M (SD)Baseline M (SD)Treatment Hedge’s g* PAND r2 
iBT Group 
Child 1 73.62 (2.21) 77.38 (3.75) 0.94 63.89 0.22 
Child 2 59.50 (3.91) 61.33 (2.86) 0.55 47.06 0.09 
Child 3 - - - - - 
Child 4 82.90 (4.56) 87.61 (3.55) 1.15 70.59 0.3 
Child 5 85.63 (0.83) 86.85 (3.11) 0.37 55.88 0.04 
Mean 75.41 (2.88) 78.29 (3.32) 0.75 59.35 0.16 
aBT Group 
Child 1 88.41 (1.17) 90.66 (1.42) 1.46 79.41 0.41 
Child 2 - - - - - 
Child 3 86.01 (2.77) 87.66 (2.87) 0.55 75.86 0.09 
Child 4 72.55 (1.93) 73.22 (2.93) 0.21 57.5 0.01 
Child 5 102.70 (1.64) 100.37 (1.99) -1.07 69.44 0.27 
Mean 87.42 (1.88) 87.98 (2.31) 0.29 70.55 0.19 
BT Group 
Child 1 62.93 (0.92) 67.30 (1.75) 2.34 97.56 0.64 
Child 2 88.74 (3.18) 84.06 (4.12) -1.05 75 0.26 
Child 3 86.14 (3.95) 90.87 (2.27) 1.72 88.89 0.49 
Child 4 102.94 (4.29) 108.46 (2.30) 1.87 94.77 0.53 
Child 5 81.29 (2.72) 83.41 (1.84) 0.96 52.94 0.23 
Mean 84.41 (3.01) 86.82 (2.45) 1.17 81.83 0.43 
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